Agenda

Summit Schedule

The speeches and discussions of the day are centered around two main focus points – “Health data and infrastructure” and “Empowering healthcare innovations”.

  • Part 1

    November 26, 2021

  • Part 2

    November 26, 2021

  • Prashant will discuss opportunities using Federated Learning to enable AI collaboration between hospitals without sharing sensitive patient data.

  • Do what is important to patients. To offer high-quality diabetes care in such a way that diabetes complications in our (young) patients can be prevented as much as possible in the future. Continuously measure the results and try to improve even more. Be transparent about the results so that patients know who is achieving which results.

  • A novel approach will be presented for privacy-preserving Data Discovery and Ethics-by-Design Patient Engagement, already empowering 160 000+ patients in 6+ disease domains worldwide

  • Smartomica is a Latvia-based biotech company focused on the development of comprehensive AI-based solutions to translate scientific data specifically relevant for each individual patient into clinically applicable products for the benefits of both the doctor and the patient.

  • Importance of availability of patients' data for secondary use - preliminary conclusions from the University of Latvia project "Survival of non-small cell lung cancer (NSCLC) patients in Latvia: essential aspects of using a value-based health care (VBHC)"

  • Data will save people lives. Data collaborative is aiming at improved decision making in prevention, early detection and management of gastric cancer and its premalignant lesions by scalable, data-agnostic, data-driven, AI-powered trusted data sharing and by combining various federated data sets; this project is expected to serve as a demonstrator for similar approaches in other conditions.

  • The introduction of Next Generation Sequencing in clinical practice opens new horizons for precision oncology. Targeted and effective treatment approaches based on genetic and molecular understanding of the cancer are increasingly practiced in treatment of children and provide new opportunities to improve cancer cure rates and health outcomes – survival and quality of life. The systematic interpretation of increasing amounts of sequencing data, aiming to translate molecular alterations into clinical decisions are challenging and are addressed via the implementation of Molecular Tumor Boards.

  • Panel discussion on how meaningful data can improve patient journey and support healthcare professionals’ work and quality of services.

  • What are the problems? Focusing on health data issues and current statistics.

  • Public-private partnership about better use of Health data, Danish Health data project OSCAR

  • Using digital pathways for recruitment, participation and follow-up of screening processes to detect cancer and infectious diseases have shown to be valuable in public health policies. Learning from aggregated data and data from individual citizens for risk stratification and personalization could be an important step ahead of us. Some perspectives for the three nationwide cancer screening programmes in The Netherlands.

  • AI addaption in Latvian healthcare system in hospital of Traumatology and Orthopaedics by DATAMED

  • VREACH is a VR-based medical rehabilitation tool for specialists aiming to conduct highly-customized and engaging sessions for children with different functional disorders. VREACH highlights patients' experience together with the timely, effective and measurable process, which are the key towards rehabilitation goal achievements.

  • While healthcare systems have been slow to adopt value-based care models, digital health startups, like Vigo Health, are ready to embrace risk-based payment schemes and deliver dramatically improved health outcomes without spending more.

  • LightSpace Technologies develops Augmented Reality headset which is the first AR device to be able to reconstruct objects up to the smallest detail, creating high resolution, optically precise near-life image to ensure precise overlay onto patient at the most optimal viewing distance - to support surgeons in pre-operating process to plan the surgery and as a real time visual guidance during surgery in which CT and MRI scans are showed as overlays to guide the surgeon to make more precise cuttings, reduce error factor and make the procedure less invasive.

  • Panel discussion on how the public sector can thrive through public-private partnerships and the role policy, regulatory and support framework plays in encouraging or hindering innovation.